Interleukin-6: A multifunctional targetable cytokine in human prostate cancer

od Culig, Zoran, Puhr, Martin
Izdano 2012

Inhibition of Nox4‐dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal‐mediated protumorigenic interactions

od Sampson, Natalie, Brunner, Elena, Weber, Anja, Puhr, Martin, Schäfer, Georg, Szyndralewiez, Cedric, Klocker, Helmut
Izdano u Int J Cancer (2018)

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide

od Hoefer, Julia, Akbor, Mohammady, Handle, Florian, Ofer, Philipp, Puhr, Martin, Parson, Walther, Culig, Zoran, Klocker, Helmut, Heidegger, Isabel
Izdano u Oncotarget (2016)

Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature

od Pircher, Andreas, Schäfer, Georg, Eigentler, Andrea, Pichler, Renate, Puhr, Martin, Steiner, Eberhard, Horninger, Wolfgang, Gunsilius, Eberhard, Klocker, Helmut, Heidegger, Isabel
Izdano u Int J Med Sci (2019)

PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells

od Puhr, Martin, Hoefer, Julia, Neuwirt, Hannes, Eder, Iris E., Kern, Johann, Schäfer, Georg, Geley, Stephan, Heidegger, Isabel, Klocker, Helmut, Culig, Zoran
Izdano u Oncotarget (2014)

The role of epithelial–mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel‐resistant prostate cancer

od Hanrahan, Karen, O'Neill, Amanda, Prencipe, Maria, Bugler, Jane, Murphy, Lisa, Fabre, Aurelie, Puhr, Martin, Culig, Zoran, Murphy, Keefe, Watson, R. William
Izdano u Mol Oncol (2017)

Antidiabetic drugs influence molecular mechanisms in prostate cancer

od Pircher, Andreas, Zieher, Martin, Eigentler, Andrea, Pichler, Renate, Schäfer, Georg, Fritz, Josef, Puhr, Martin, Steiner, Eberhard, Horninger, Wolfgang, Klocker, Helmut, Heidegger, Isabel
Izdano u Cancer Biol Ther (2018)

p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer

od Gruber, Martina, Ferrone, Lavinia, Puhr, Martin, Santer, Frédéric R, Furlan, Tobias, Eder, Iris E, Sampson, Natalie, Schäfer, Georg, Handle, Florian, Culig, Zoran
Izdano u Endocr Relat Cancer (2020)

Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinase...

od Neuwirt, Hannes, Puhr, Martin, Santer, Frédéric R., Susani, Martin, Doppler, Wolfgang, Marcias, Gemma, Rauch, Veronika, Brugger, Maria, Hobisch, Alfred, Kenner, Lukas, Culig, Zoran
Izdano 2009

Akacid Medical Formulation Induces Apoptosis in Myeloid and Lymphatic Leukemic Cell Lines In Vitro and In Vivo

od Neuwirt, Hannes, Wabnig, Elisabeth, Feistritzer, Clemens, Eder, Iris E., Salvador, Christina, Puhr, Martin, Culig, Zoran, Massoner, Petra, Tiefenthaler, Martin, Steurer, Michael, Konwalinka, Guenther
Izdano u PLoS One (2015)

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells

od Ippolito, Luigi, Marini, Alberto, Cavallini, Lorenzo, Morandi, Andrea, Pietrovito, Laura, Pintus, Gianfranco, Giannoni, Elisa, Schrader, Thomas, Puhr, Martin, Chiarugi, Paola, Taddei, Maria Letizia
Izdano u Oncotarget (2016)

Suppressor of Cytokine Signaling-3 Antagonizes cAMP Effects on Proliferation and Apoptosis and Is Expressed in Human Prostate Cancer

od Bellezza, Ilaria, Neuwirt, Hannes, Nemes, Constanze, Cavarretta, Ilaria T., Puhr, Martin, Steiner, Hannes, Minelli, Alba, Bartsch, Georg, Offner, Felix, Hobisch, Alfred, Doppler, Wolfgang, Culig, Zoran
Izdano 2006

Enhanced Inhibition of Prostate Tumor Growth by Dual Targeting the Androgen Receptor and the Regulatory Subunit Type Iα of Protein Kinase A in Vivo

od Eder, Iris E., Egger, Martina, Neuwirt, Hannes, Seifarth, Christof, Maddalo, Danilo, Desiniotis, Andreas, Schäfer, Georg, Puhr, Martin, Bektic, Jasmin, Cato, Andrew C. B., Klocker, Helmut
Izdano 2013

Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer

od Puhr, Martin, Eigentler, Andrea, Handle, Florian, Hackl, Hubert, Ploner, Christian, Heidegger, Isabel, Schaefer, Georg, Brandt, Maximilian P., Hoefer, Julia, Van der Pluijm, Gabri, Klocker, Helmut
Izdano u Oncogene (2021)

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer

od Hoefer, Julia, Kern, Johann, Ofer, Philipp, Eder, Iris E, Schäfer, Georg, Dietrich, Dimo, Kristiansen, Glen, Geley, Stephan, Rainer, Johannes, Gunsilius, Eberhard, Klocker, Helmut, Culig, Zoran, Puhr, Martin
Izdano 2014

miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer

od Pasqualini, Lorenza, Bu, Huajie, Puhr, Martin, Narisu, Narisu, Rainer, Johannes, Schlick, Bettina, Schäfer, Georg, Angelova, Mihaela, Trajanoski, Zlatko, Börno, Stefan T., Schweiger, Michal R., Fuchsberger, Christian, Klocker, Helmut
Izdano u Mol Endocrinol (2015)

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

od Drápela, Stanislav, Khirsariya, Prashant, van Weerden, Wytske M., Fedr, Radek, Suchánková, Tereza, Búzová, Diana, Červený, Jan, Hampl, Aleš, Puhr, Martin, Watson, William R., Culig, Zoran, Krejčí, Lumír, Paruch, Kamil, Souček, Karel
Izdano u Mol Oncol (2020)

Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo

od Gu, Lei, Vogiatzi, Paraskevi, Puhr, Martin, Dagvadorj, Ayush, Lutz, Jacqueline, Ryder, Amy, Addya, Sankar, Fortina, Paolo, Cooper, Carlton, Leiby, Benjamin, Dasgupta, Abhijit, Hyslop, Terry, Bubendorf, Lukas, Alanen, Kalle, Mirtti, Tuomas, Nevalainen, Marja T
Izdano u Endocr Relat Cancer (2010)

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer

od Kroon, Jan, Puhr, Martin, Buijs, Jeroen T, van der Horst, Geertje, Hemmer, Daniëlle M, Marijt, Koen A, Hwang, Ming S, Masood, Motasim, Grimm, Stefan, Storm, Gert, Metselaar, Josbert M, Meijer, Onno C, Culig, Zoran, van der Pluijm, Gabri
Izdano u Endocr Relat Cancer (2016)

ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat

od Meidhof, Simone, Brabletz, Simone, Lehmann, Waltraut, Preca, Bogdan-Tiberius, Mock, Kerstin, Ruh, Manuel, Schüler, Julia, Berthold, Maria, Weber, Anika, Burk, Ulrike, Lübbert, Michael, Puhr, Martin, Culig, Zoran, Wellner, Ulrich, Keck, Tobias, Bronsert, Peter, Küsters, Simon, Hopt, Ulrich T, Stemmler, Marc P, Brabletz, Thomas
Izdano u EMBO Mol Med (2015)